Lipella Pharmaceuticals Statistics
Total Valuation
LIPO has a market cap or net worth of $6.24 million. The enterprise value is $4.11 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LIPO has 2.55 million shares outstanding. The number of shares has increased by 39.69% in one year.
| Current Share Class | 2.55M |
| Shares Outstanding | 2.55M |
| Shares Change (YoY) | +39.69% |
| Shares Change (QoQ) | +8.12% |
| Owned by Insiders (%) | 8.71% |
| Owned by Institutions (%) | 4.60% |
| Float | 2.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.79 |
| Forward PS | n/a |
| PB Ratio | 1.54 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.47 |
| Quick Ratio | 3.01 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -198.12% and return on invested capital (ROIC) is -121.01%.
| Return on Equity (ROE) | -198.12% |
| Return on Assets (ROA) | -101.59% |
| Return on Invested Capital (ROIC) | -121.01% |
| Return on Capital Employed (ROCE) | -264.69% |
| Revenue Per Employee | $76,622 |
| Profits Per Employee | -$716,609 |
| Employee Count | 7 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.93% in the last 52 weeks. The beta is 0.31, so LIPO's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -56.93% |
| 50-Day Moving Average | 2.58 |
| 200-Day Moving Average | 3.17 |
| Relative Strength Index (RSI) | 47.99 |
| Average Volume (20 Days) | 172,322 |
Short Selling Information
The latest short interest is 17,271, so 0.68% of the outstanding shares have been sold short.
| Short Interest | 17,271 |
| Short Previous Month | 20,718 |
| Short % of Shares Out | 0.68% |
| Short % of Float | 0.74% |
| Short Ratio (days to cover) | 0.47 |
Income Statement
In the last 12 months, LIPO had revenue of $536,357 and -$5.02 million in losses. Loss per share was -$4.79.
| Revenue | 536,357 |
| Gross Profit | -3.08M |
| Operating Income | -5.08M |
| Pretax Income | -4.74M |
| Net Income | -5.02M |
| EBITDA | -5.08M |
| EBIT | -5.08M |
| Loss Per Share | -$4.79 |
Full Income StatementBalance Sheet
The company has $2.18 million in cash and $47,605 in debt, giving a net cash position of $2.14 million or $0.84 per share.
| Cash & Cash Equivalents | 2.18M |
| Total Debt | 47,605 |
| Net Cash | 2.14M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 1.92M |
| Book Value Per Share | 1.59 |
| Working Capital | 1.86M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.95M |
| FCF Per Share | -$1.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -947.23% |
| Pretax Margin | -935.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |